Davuluri, Rajayogesh <br/><br/>
Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  09 2017 
 - 128-135 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2017.05.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--immunology<br/>Carcinoma, Squamous Cell--immunology<br/>Chemoradiotherapy--adverse effects<br/>Esophageal Neoplasms--immunology<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Incidence<br/>Kaplan-Meier Estimate<br/>Lymphocyte Count<br/>Lymphopenia--epidemiology<br/>Middle Aged<br/>Monocytes--drug effects<br/>Neutrophils--drug effects<br/>Odds Ratio<br/>Platinum Compounds--therapeutic use<br/>Proportional Hazards Models<br/>Proton Therapy<br/>Radiotherapy Dosage<br/>Regression Analysis<br/>Retrospective Studies<br/>T-Lymphocytes--drug effects<br/>Taxoids--therapeutic use<br/>Treatment Outcome